Ufuk Kirik, Associate Director of Data Science at AstraZeneca, discussed the use of graph technology in drug discovery and highlighted Neo4j as a key tool for his work. He emphasized the importance of not being afraid to try new things and encouraged others to "dip their toes in the water" when getting started with Neo4j. Kirik praised Cypher, Neo4j's query language, for making it easy to translate difficult biological questions into queries. He also discussed the potential for future advancements in graph technology, including the integration of high-level programming languages and the ability to quickly adapt data models. As AstraZeneca works to identify new drug targets using graph data science, Kirik's insights provide a glimpse into the exciting possibilities emerging in this field.